Lenar T Yessayan
Clinical Professor of Internal Medicine
Medical Director, MPLAN - Inpatient Hemodialysis
Medical Director, MDS Dialysis Unit
Ann Arbor
MI
48109,
[email protected]

Available to mentor
Lenar T Yessayan
Clinical Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Center for Integrative Research in Critical Care
    Recent Publications See All Publications
    • Journal Article
      Immunomodulatory Effect of Selective Cytopheretic Device (SCD) on Neutrophil-to-Lymphocyte Ratio (NLR) and Hematologic Parameters from Multiple AKI Trials
      Iyer SPN, Ollberding NJ, Koyner JL, Yessayan LT, Chung KK, Humes HD. Journal of the American Society of Nephrology, 2024 Oct; 35 (10S): 10.1681/asn.2024az0471n4 DOI:10.1681/asn.2024az0471n4
    • Journal Article
      Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions.
      Iyer SPN, Pino CJ, Yessayan LT, Goldstein SL, Weir MR, Westover AJ, Catanzaro DA, Chung KK, Humes HD. Transplant Direct, 2024 Jun; 10 (6): e1627 DOI:10.1097/TXD.0000000000001627
      PMID: 38769980
    • Journal Article
      Selective Cytopheretic Device Use in Continuous Kidney Replacement Therapy in Children: A Cohort Study With a Historical Comparator.
      Goldstein SL, Ollberding NJ, Askenazi DJ, Basu RK, Selewski DT, Krallman KA, Yessayan L, Humes HD. Kidney Med, 2024 Apr; 6 (4): 100792 DOI:10.1016/j.xkme.2024.100792
      PMID: 38576525
    • Journal Article
      1349: A REAL-WORLD DESCRIPTION OF MEDICATION DOSE ADJUSTMENT USING CYSTATIN C IN CRITICALLY ILL ADULTS
      Farina N, Kenes M, Yessayan L, Ingebrigston M. Critical Care Medicine, 2024 Jan; 52 (1): s646 - s646. DOI:10.1097/01.ccm.0001003556.03695.67
    • Journal Article
      Rationale and Design of NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy.
      Yessayan L, Humes HD, Scribe EC, Iyer SPN, Chung KK. Nephron, 2024 148 (1): 43 - 53. DOI:10.1159/000531880
      PMID: 37442112
    • Journal Article
      Proceedings of the 2022 UAB CRRT Academy: Non-Invasive Hemodynamic Monitoring to Guide Fluid Removal with CRRT and Proliferation of Extracorporeal Blood Purification Devices.
      Teixeira JP, Zeidman A, Beaubien-Souligny W, Cerdá J, Connor MJ, Eggleston K, Juncos LA, da Silva JR, Wells C, Yessayan L, Barker AB, McConville W, Speer R, Wille KM, Neyra JA, Tolwani A. Blood Purif, 2023 52 (11-12): 857 - 879. DOI:10.1159/000533573
      PMID: 37742622
    • Journal Article
      Hemolytic Uremic Syndrome-Induced Acute Kidney Injury Treated via Immunomodulation with the Selective Cytopheretic Device.
      Hambrick HR, Short K, Askenazi D, Krallman K, Pino C, Yessayan L, Westover A, Humes HD, Goldstein SL. Blood Purif, 2023 52 (9-10): 812 - 820. DOI:10.1159/000531963
      PMID: 37607519
    • Proceeding / Abstract / Poster
      Role of Immunomodulation Therapy with Selective Cytopheretic Device (SCD) in Reversing Acute on Chronic Liver Failure (ACLF) with Hepatorenal Syndrome (HRS) and Multi-Organ Failure
      Yessayan LT, Sharma P, Westover A, Szamosfalvi B, Humes HD. Journal of the American Society of Nephrology, 2023 Nov 1; 34 (11S): 443 - 443. DOI:10.1681/asn.20233411s1443c